Jerome J. Lande - May 31, 2024 Form 4 Insider Report for CONMED Corp (CNMD)

Role: Director
Signature: /s/ Thomas Fistek for Jerome J. Lande by Power of Attorney
Stock symbol: CNMD
Transactions as of: May 31, 2024
Transactions value $: $0
Form type: 4
Date filed: 6/4/2024, 09:17 PM
Previous filing: Apr 2, 2024
Next filing: Jul 2, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CNMD	Common Stock	Options Exercise	$0	+302	+8.5%	$0.00	3.86K	May 31, 2024	Direct
holding	CNMD	Common Stock						0	May 31, 2024	Coppersmith Capital Management, LLC	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CNMD	Rsus (restricted Stock Units)	Options Exercise	$0	-302	-100%	$0.00^*	0	May 31, 2024	Common Stock	302	$0.00	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Mr. Lande, as a Managing Member of Coppersmith Capital Management, LLC ("Coppersmith Capital"), may be deemed the beneficial owner of the 1,630,800 shares of Common Stock, $0.01 par value ("Common Stock") beneficially owned by Coppersmith Capital, the Investment Adviser to a number of investment funds or managed accounts. Mr. Lande disclaims beneficial ownership of such Common Stock except to the extent of his pecuniary interest therein.
F2	Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.

Content

Mr. Lande, as a Managing Member of Coppersmith Capital Management, LLC ("Coppersmith Capital"), may be deemed the beneficial owner of the 1,630,800 shares of Common Stock, $0.01 par value ("Common Stock") beneficially owned by Coppersmith Capital, the Investment Adviser to a number of investment funds or managed accounts. Mr. Lande disclaims beneficial ownership of such Common Stock except to the extent of his pecuniary interest therein.

Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.